Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
10.7M
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
519K
-
Shares change
-
+473K
-
Total reported value, excl. options
-
$561K
-
Value change
-
+$512K
-
Number of buys
-
6
-
Number of sells
-
-1
-
Price
-
$1.08
Significant Holders of Dermata Therapeutics, Inc. - Common Stock, par value $0.0001 per share (DRMA) as of Q1 2025
8 filings reported holding DRMA - Dermata Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Dermata Therapeutics, Inc. - Common Stock, par value $0.0001 per share (DRMA) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 519K shares
of 10.7M outstanding shares and own 4.86% of the company stock.
Largest 8 shareholders include ARMISTICE CAPITAL, LLC (411K shares), UBS Group AG (70.3K shares), GEODE CAPITAL MANAGEMENT, LLC (20.4K shares), JONES FINANCIAL COMPANIES LLLP (12K shares), WELLS FARGO & COMPANY/MN (2K shares), Tower Research Capital LLC (TRC) (1.8K shares), SBI Securities Co., Ltd. (1K shares), and BANK OF AMERICA CORP /DE/ (21 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.